Polonio-Alcalá, E.; Palomeras, S.; Torres-Oteros, D.; Relat, J.; Planas, M.; Feliu, L.; Ciurana, J.; Ruiz-Martínez, S.; Puig, T.
Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models. Cancers 2020, 12, 1283.
https://doi.org/10.3390/cancers12051283
AMA Style
Polonio-Alcalá E, Palomeras S, Torres-Oteros D, Relat J, Planas M, Feliu L, Ciurana J, Ruiz-Martínez S, Puig T.
Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models. Cancers. 2020; 12(5):1283.
https://doi.org/10.3390/cancers12051283
Chicago/Turabian Style
Polonio-Alcalá, Emma, Sònia Palomeras, Daniel Torres-Oteros, Joana Relat, Marta Planas, Lidia Feliu, Joaquim Ciurana, Santiago Ruiz-Martínez, and Teresa Puig.
2020. "Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models" Cancers 12, no. 5: 1283.
https://doi.org/10.3390/cancers12051283
APA Style
Polonio-Alcalá, E., Palomeras, S., Torres-Oteros, D., Relat, J., Planas, M., Feliu, L., Ciurana, J., Ruiz-Martínez, S., & Puig, T.
(2020). Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models. Cancers, 12(5), 1283.
https://doi.org/10.3390/cancers12051283